Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Brainstorm Cell Therapeutics Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 5 | 0 | −5 |
| Shares | 2.32K | 0 | −2.32K (−100.0%) |
| Value | $1.73K | $0 | −$1.73K (−100.0%) |
New holders (0)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q4 2025 but not at the end of Q3 2025.
None.
Sold out (5)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Advisor Group Holdings, Inc. | 1,785 | $1.35K |
| Bangor Savings Bank | 266 | $188 |
| VSM Wealth Advisory, LLC | 120 | $85 |
| Steward Partners Investment Advisory, LLC | 113 | $80 |
| St Germain D J Co Inc | 33 | $23 |